ICLR – icon plc - ordinary shares (US:NASDAQ)

News

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
Icon (NASDAQ:ICLR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Icon (NASDAQ:ICLR) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.
FMI Global Equity Q3 2025 Commentary [Seeking Alpha]
Icon PLC (ICLR) Down 12.2% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com